The panel will discuss models for financing drug development that are designed to share development risk and also provide for profit and loss sparing under U.S. and international accounting. Panelists will cover the business, accounting and legal issues associated with the various structures; the pros and cons and the pitfalls associated with these structures.
- Explore the benefits of these financing models from a business point of view
- Review how these structures are designed from an accounting and legal point of view
- Examine the economics associated with these financings
Ability Level: All
Session ID: 2479